Tikosyn shortage over
Executive Summary
Pfizer is sending "Dear Healthcare Professional" letters alerting physicians that shortages for its atrial fibrillation/atrial flutter therapy Tikosyn are resolved, the company announces Feb. 1. The outages for 0.25 mg and 0.5 mg doses of dofetilide resulted from manufacturing issues that do not impact Tikosyn's safety or efficacy, Pfizer states...